Diabetes Mellitus and Heart Failure

The American Journal of Medicine
Michael Lehrke, Nikolaus Marx


Epidemiologic and clinical data from the last 2 decades have shown that the prevalence of heart failure in diabetes is very high, and the prognosis for patients with heart failure is worse in those with diabetes than in those without diabetes. Experimental data suggest that various mechanisms contribute to the impairment in systolic and diastolic function in patients with diabetes, and there is an increased recognition that these patients develop heart failure independent of the presence of coronary artery disease or its associated risk factors. In addition, current clinical data demonstrated that treatment with the sodium glucose cotransporter 2 inhibitor empagliflozin reduced hospitalization for heart failure in patients with type 2 diabetes mellitus and high cardiovascular risk. This review article summarizes recent data on the prevalence, prognosis, pathophysiology, and therapeutic strategies to treat patients with diabetes and heart failure.


Nov 8, 1972·The American Journal of Cardiology·S RublerA Grishman
Sep 5, 2002·Circulation·Scott D SolomonUNKNOWN Survival And Ventricular Enlargement (SAVE) Investigators
Mar 5, 2004·Journal of the American College of Cardiology·Ida GustafssonUNKNOWN Danish Investigatord of Arrhythmia and Mortality on Dofetilde Study Group
Jul 28, 2004·Diabetes Care·Gregory A NicholsJonathan B Brown
Jan 22, 2005·Science·Bradford B Lowell, Gerald I Shulman
Sep 20, 2005·Journal of the American College of Cardiology·Wolfram DoehnerStefan D Anker
Mar 16, 2007·The New England Journal of Medicine·Stefan Neubauer
Dec 2, 2008·Molecular and Cellular Endocrinology·David Russell-Jones
Jun 9, 2009·The New England Journal of Medicine·UNKNOWN BARI 2D Study GroupBurton E Sobel
Apr 22, 2010·The Journal of Clinical Investigation·Ippei ShimizuIssei Komuro
Jul 14, 2010·Journal of the American College of Cardiology·Luuk J RijzewijkHildo J Lamb
Sep 22, 2010·The American Journal of Cardiology·Josie M M EvansChim C Lang
Oct 19, 2010·Circulation. Heart Failure·David AguilarAnita Deswal
Oct 30, 2010·Circulation Research·Ferdinando Giacco, Michael Brownlee
Oct 20, 2011·Circulation Journal : Official Journal of the Japanese Circulation Society·Yuya MatsueYuji Hashimoto
Jan 21, 2012·The Review of Diabetic Studies : RDS·Michael Lehrke, Nikolaus Marx
Mar 30, 2012·Current Heart Failure Reports·Ravichandran Ramasamy, Ann Marie Schmidt
May 1, 2012·European Heart Journal Cardiovascular Imaging·Krishna Kishor KadappuLiza Thomas
May 9, 2012·Cell Metabolism·Christopher K Glass, Jerrold M Olefsky
May 29, 2012·Archives of Cardiovascular Diseases·Laura Ernande, Geneviève Derumeaux
Sep 5, 2012·Nature Reviews. Endocrinology·Juris J Meier
Apr 9, 2013·Cell Metabolism·Marc Liesa, Orian S Shirihai
Jun 12, 2013·Journal of the American College of Cardiology·Clyde W YancyUNKNOWN American Heart Association Task Force on Practice Guidelines
Jun 26, 2013·The New England Journal of Medicine·Rena R WingSusan Z Yanovski
Sep 3, 2013·The New England Journal of Medicine·Benjamin M SciricaUNKNOWN SAVOR-TIMI 53 Steering Committee and Investigators
Sep 3, 2013·The New England Journal of Medicine·William B WhiteUNKNOWN EXAMINE Investigators
Sep 27, 2014·Journal of the American College of Cardiology·Wolfram DoehnerStefan D Anker
Dec 3, 2014·Journal of the American College of Cardiology·Tariq AhmadG Michael Felker

❮ Previous
Next ❯


May 21, 2017·The American Journal of Medicine·James Thrasher
May 21, 2017·The American Journal of Medicine·Son V Pham, Robert Chilton
Apr 29, 2018·Heart Failure Reviews·Joaquim Silva CustodioLeonardo Roever
May 19, 2018·European Journal of Cardiovascular Nursing : Journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology·Lihua WuChristi Deaton
Sep 14, 2018·Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology·Dharmender MalikAjay Bahl
Feb 14, 2019·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Viswanathan MohanKamlesh Khunti
Jun 15, 2019·The Diabetes Educator·Fekadu B AgaRebecca A Gary
Dec 22, 2019·Journal of Cachexia, Sarcopenia and Muscle·Jack O GarnhamKlaus K Witte
Mar 7, 2020·Future Cardiology·Izza ShahidFarouk Mookadam
Jan 15, 2020·Cell and Tissue Research·Simone RennerEckhard Wolf
Feb 23, 2019·International Journal of Molecular Sciences·Garrison J B DyckJustin A Ezekowitz
May 2, 2018·Scientific Reports·Ekaterina BiterovaLloyd W Ruddock
Apr 11, 2020·Frontiers in Endocrinology·Jana BreitfeldPeter Kovacs
Jun 23, 2018·Frontiers in Cardiovascular Medicine·Stephen C Kolwicz
Nov 5, 2019·Biochimica Et Biophysica Acta. Molecular Basis of Disease·Jan F C GlatzJoost J F P Luiken
Nov 26, 2020·Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy·Yue QiuDong Wang
Oct 28, 2020·Canadian Journal of Physiology and Pharmacology·Suzan M MansourHala F Zaki
Jun 18, 2021·The Nurse Practitioner·Christy McDonald LenahanFrances Stueben
Sep 10, 2021·Frontiers in Pharmacology·A UryashJ R Lopez
Nov 5, 2021·Heart Failure Reviews·Daniele MasaroneGiuseppe Pacileo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.